2001
DOI: 10.1007/s10434-001-0658-4
|View full text |Cite
|
Sign up to set email alerts
|

Does Complete Resection of Melanoma Metastatic to Solid Intra-Abdominal Organs Improve Survival?

Abstract: In highly selected patients with melanoma metastatic to intra-abdominal solid organs, aggressive attempts at complete surgical resection may improve OS. It is important that the number of metastatic sites does not seem to affect the OS after complete resection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
67
1
4

Year Published

2006
2006
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 139 publications
(75 citation statements)
references
References 20 publications
3
67
1
4
Order By: Relevance
“…In many cases, it is palliative, improving symptoms and quality of life; in selected cases, it can be able to increase overall survival (OS) [3].…”
Section: Introductionmentioning
confidence: 99%
“…In many cases, it is palliative, improving symptoms and quality of life; in selected cases, it can be able to increase overall survival (OS) [3].…”
Section: Introductionmentioning
confidence: 99%
“…Patients who have been felt to be suitable for resection of (stage IV) metastatic melanoma have an improved survival over those treated palliatively, with median survival times of 11-27 months [9,25] compared with 4-14 months in patients not undergoing splenectomy [9,25]. Very occasionally, longterm disease-free survival after metastatectomy for malignant melanoma has been described [9], but the median time to disease recurrence is 2 months [9] and in patients where it is not possible to achieve an R0 resection, outcome is similar to non-operative management [25].…”
Section: Discussionmentioning
confidence: 99%
“…Patients with tumours with the least aggressive natural course, those most sensitive to chemotherapy and those with an improvement in outcome associated with cytoreductive surgery [21,22] are those who are most likely to benefit from resection of their splenic disease whereas no benefit is seen in incomplete resection of disease in other tumours [25].…”
Section: Discussionmentioning
confidence: 99%
“…Previou patients with m Diagnosis is g FDG PET/CT survival in the prolong surviv durable [96] . Ne Table 7.…”
Section: Melamentioning
confidence: 99%
“…Ne Table 7. Liver Author Rose [93] Wood [100] Hsueh [101] Pawlik [98] Crook [102] Adam [49] Herman [103] Chua [104] A and a slowing o Table 7). A larg ma of choroida rce [49] .…”
Section: Melamentioning
confidence: 99%